Fig. 5a
From: IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience
Relapse-free survival according to mutational status (localized patients). The 5-years RFS in localized patients was 33% (95% CI:10-57) in IDHmut and 57% (95%CI: 30-77) in IDHwt (p=0.3596)